Back to search

Netherlands· NL-861727a88df5

Sugammadex Gebro 100 mg/ml oplossing voor injectie

A sugammadex product containing sugammadex natrium, registered in Netherlands by Gebro Pharma GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC V03AB35

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSugammadex Gebro 100 mg/ml oplossing …ATCV03AB35REGISTER NO.NL-861727a88df5PACKS LISTED1CHECKEDJuly 28, 2026

Where it is registered

Sugammadex is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AB35 (sugammadex), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Sugammadex · ATC V03AB35

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SUGAMMADEX NATRIUM
Manufacturer
Gebro Pharma GmbH
Country
Netherlands (NL)
ATC code
V03AB35
ATC class
Sugammadex
Defined daily dose
0.28 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
July 28, 2026

Packs & prices · 1

  • cbg_meb_id
    129269

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

34 interactions on record for sugammadex.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sugammadex · interactions on record

34 records

  • 14 severe
  • 20 moderate

Most severe, free to view

  • IUP aus Plastik mit GestagenG02BA03severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • NorethisteroneG03AC01severe
  • LevonorgestrelG03AC03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sugammadex in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sugammadex products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Areversin, Sugagelan
  • Belgium · Sugammadex, Sugammadex Aguettant
  • Bulgaria · Сугамадекс Аптафарма, Сугамадекс Ромфарм
  • Cyprus · Sugammadex Accord, Sugammadex Anabiosis
  • Czechia · Blovovan, Nobridex
  • Germany · Areversin, Risvedex Ibi
  • Denmark · Sugammadex "aguettant" Aguettant, Sugammadex "kalceks"
  • Estonia · Sugammadex Accord, Sugammadex Kalceks
  • Spain · Sugammadex, Sugammadex Accord
  • Finland · Sugammadex Accord, Sugammadex Aguettant
  • France · Sugammadex, Sugammadex Accord
  • United Kingdom (Northern Ireland) · Sugammadex, Sugammadex 100 Mg/Ml Solution For Injection Wockhardt Uk
  • Greece · Blovovan, Sugammadex Anabiosis
  • Croatia · Areversin, Sugamadeks Accord
  • Hungary · Areversin, Sugammadex Aguettant
  • Ireland · Sugammadex, Sugammadex Accord Healthcare Ireland
  • Iceland · Bridion, Sugammadex Amomed
  • Italy · Risvedex Ibi, Sugammadex Abdi Farma
  • Liechtenstein · Bridion, Sugammadex Amomed
  • Lithuania · Sugammadex Accord, Sugammadex Kalceks
  • Luxembourg · Sugammadex Eg, Sugammadex Eg (Eurogenerics)
  • Latvia · Sugammadex Kalceks, Sugammadex Msn
  • Malta · Sugammadex Anfarm, Sugammadex Aspen
  • Norway · Bridion, Sugammadex Accord
  • Poland · Sugammadex Accord, Sugammadex Aguettant
  • Portugal · Sugamadex Accord, Sugamadex Aguettant
  • Romania · Areversin, Sugammadex Accord
  • Sweden · Sugamadex Galenicum, Sugammadex Accord
  • Slovenia · Sugamadeks, Sugamadeks Aptapharma
  • Slovakia · Areversin, Sugammadex Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1ca74dd-01f5-4a5c-8614-9fb3851336e4
GET /v1/drugs/f1ca74dd-01f5-4a5c-8614-9fb3851336e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129269_smpc.pdf",
  "strength": null,
  "atc_label": "Sugammadex",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129269",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "SUGAMMADEX NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129269.pdf",
  "authorised_at": "2023/01/10",
  "procedure_number": "HU/H/0812/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129269",
  "additional_monitoring": "N"
}

See everything about sugammadex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.